Proteomic Analysis of Human Plasma during Intermittent Fasting

[Image: see text] Intermittent fasting (IF) increases lifespan and decreases metabolic disease phenotypes and cancer risk in model organisms, but the health benefits of IF in humans are less clear. Human plasma derived from clinical trials is one of the most difficult sample sets to analyze using ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Harney, Dylan J., Hutchison, Amy T., Hatchwell, Luke, Humphrey, Sean J., James, David E., Hocking, Samantha, Heilbronn, Leonie K., Larance, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2019
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503536/
https://www.ncbi.nlm.nih.gov/pubmed/30892045
http://dx.doi.org/10.1021/acs.jproteome.9b00090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503536/
https://www.ncbi.nlm.nih.gov/pubmed/30892045
http://dx.doi.org/10.1021/acs.jproteome.9b00090

Ejemplares similares